Standard Glass Lining Technology Ltd
Incorporated in September 2012, Standard Glass Lining Technology Limited is a manufacturer of engineering equipment for the pharmaceutical and chemical sectors in India.[1]
- Market Cap ₹ 3,838 Cr.
- Current Price ₹ 192
- High / Low ₹ 214 / 124
- Stock P/E 54.5
- Book Value ₹ 35.4
- Dividend Yield 0.00 %
- ROCE 16.5 %
- ROE 11.6 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Debtor days have increased from 99.4 to 127 days.
- Working capital days have increased from 172 days to 272 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Industrials Capital Goods Industrial Manufacturing Industrial Products
Part of BSE SmallCap BSE IPO BSE Allcap BSE Industrials
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|
| 240 | 498 | 544 | 614 | 645 | |
| 200 | 412 | 449 | 506 | 532 | |
| Operating Profit | 40 | 86 | 95 | 107 | 113 |
| OPM % | 17% | 17% | 17% | 18% | 18% |
| 1 | 2 | 6 | 12 | 15 | |
| Interest | 4 | 9 | 12 | 15 | 14 |
| Depreciation | 4 | 8 | 9 | 11 | 12 |
| Profit before tax | 34 | 72 | 80 | 94 | 102 |
| Tax % | 26% | 26% | 25% | 27% | |
| 25 | 53 | 60 | 69 | 74 | |
| EPS in Rs | 16.44 | 33.84 | 32.14 | 3.23 | 3.69 |
| Dividend Payout % | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 37% |
| TTM: | 13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 37% |
| TTM: | 10% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 19% |
| Last Year: | 12% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Equity Capital | 15 | 16 | 18 | 199 |
| Reserves | 54 | 140 | 389 | 507 |
| 70 | 82 | 129 | 68 | |
| 159 | 110 | 129 | 184 | |
| Total Liabilities | 298 | 348 | 665 | 958 |
| 52 | 75 | 96 | 136 | |
| CWIP | 1 | 3 | 4 | 8 |
| Investments | 0 | 0 | 0 | 0 |
| 245 | 269 | 565 | 814 | |
| Total Assets | 298 | 348 | 665 | 958 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| -7 | 2 | -65 | 5 | |
| -30 | -29 | -157 | -160 | |
| 37 | 33 | 232 | 141 | |
| Net Cash Flow | 0 | 5 | 10 | -14 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Debtor Days | 125 | 67 | 104 | 127 |
| Inventory Days | 399 | 183 | 258 | 296 |
| Days Payable | 198 | 96 | 102 | 115 |
| Cash Conversion Cycle | 326 | 154 | 260 | 309 |
| Working Capital Days | 53 | 66 | 178 | 272 |
| ROCE % | 43% | 24% | 16% |
Documents
Announcements
-
Announcement Under Regulation 30 (LODR) - Incorporation Of Subsidiary Company
17 Sep - Standard Glass Lining incorporated Standard Scigenics Pvt Ltd on 16 Sep 2025; 51% stake, initial cash subscription.
-
Announcement under Regulation 30 (LODR)-Change in Management
13 Sep - Shareholders appointed RPR & Associates as secretarial auditors for five-year term from 13th AGM on 12 Sep 2025.
-
Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
13 Sep - Shareholders at 12 Sep 2025 AGM approved deletion of Part B (pre-IPO shareholders' agreement) from AOA.
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report 13 Sep
- Shareholder Meeting / Postal Ballot-Outcome of AGM 12 Sep
Concalls
-
Aug 2025Transcript PPT REC
-
Jun 2025Transcript PPT REC
-
May 2025TranscriptNotesPPT
-
Feb 2025Transcript PPT
Business Overview[1] Standard Glass is among the top 5 specialized engineering equipment manufacturers for pharmaceutical and chemical sectors in India (FY24 revenue basis). It provides end-to-end solutions including design, manufacturing, assembly, installation, and commissioning of equipment with over 65+ unique designs and over 11,000 units delivered.